There is no direct evidence linking Tadalista Super Active, a brand of tadalafil used to treat erectile dysfunction, to an increased cancer risk. Tadalafil, the active ingredient in Tadalista Super Active, is a phosphodiesterase type 5 (PDE5) inhibitor that works by relaxing the muscles in blood vessels, improving blood flow. Although some studies have explored the potential effects of PDE5 inhibitors on cancer cell growth or progression, these findings are inconclusive and not sufficient to establish a clear link. However, as with any medication, it is important to consult with a healthcare provider to discuss potential risks and side effects based on individual health conditions.
 |
M'inscrire 
Me connecter 
Mot de passe oublié 
Retour au forum
